The Acute Effects of an Isometric Loading Intervention on Lower Extremity Landing Biomechanics in Individuals With Patellar Tendinopathy

February 15, 2019 updated by: University of North Carolina, Chapel Hill
The purpose of this study is to determine differences in lower extremity landing biomechanics and real-world physical activity between individuals with patellar tendinopathy compared to individuals without patellar tendinopathy,and to determine the acute effects of an isometric loading intervention on lower extremity landing biomechanics in individuals with patellar tendinopathy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • Sports Medicine Research Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 28 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

The investigators will recruit a convenience sample of participants who meet the following overall criteria:

  1. Age 15 and post-pubertal (confirmed by Pubertal Development Scale Questionnaire) - 28 years
  2. Actively participating within an organized sport setting (high school, collegiate, club, competitive intramural sports) in their respective team's weekly training and competitions, quantified by a Tegner Activity Level Scale of at least 5.

Exclusion Criteria:

The following exclusion criteria will be applied to all participants:

  1. Any anterior knee pain with no patellar tendon abnormality on ultrasound assessment.
  2. History of any knee joint surgery ever.
  3. History of other (non-knee) lower extremity surgery in the last 1 year.
  4. History of lower extremity injury in last 6 months (other than patellar tendinopathy).
  5. An injection (corticosteroids, plasma-rich-protein, etc.) to the patellar tendon in the last 3 months.
  6. Known history of osteoarthritis or current symptoms related to osteoarthritis (i.e. stiffness, swelling).
  7. Participation in formal rehabilitation for patellar tendinopathy in prior 3 months
  8. Known neurological disorders, including: stroke, multiple sclerosis, ALS, diabetic neuropathy, epilepsy, traumatic brain injury resulting in loss of consciousness, concussion within the last 6 months, cranial neural surgery, balance disorders.
  9. Use of pacemaker or another implantable electronic device.
  10. History of cardiac arrhythmia or any cardiac condition.
  11. History of psychiatric disorder. *
  12. History of cancer in the brain or thigh musculature.
  13. Pubertal Development Scale Score < 12 (Stages 1-4)

    • Note: Rationale for exclusion of individuals with a history of psychiatric disorders is that these individuals may have taken or be taking pharmacological agents that could affect pain or neuromuscular control.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Isometric Exercise Condition
The participant will perform 5 sets of a 45-second isometric contractions at 70% of their maximum voluntary isometric contraction (MVIC). During the 45-second contraction, the participant will be provided with visual biofeedback on a computer screen (70% MVIC target line and +/- 5% error lines). The participant will be instructed to produce a level of isometric quadriceps contraction that maintains the isometric torque output line as close the target line as possible and always between the two error lines.
5 sets of 45-seconds quadriceps contraction, each followed by 2-minutes of rest.
Other Names:
  • Therapeutic Exercise
SHAM_COMPARATOR: Sham TENS Condition
Two electrodes of the Select System TENS unit (Empi, Inc., St. Paul, MN) will be placed on either side of the patellar tendon on the test limb. The same instruction script will be used for each participant, stating, "A surface electrode has been placed on either side of your patellar tendon. I will turn on the stimulation unit to emit a stimulus to your patellar tendon. This is a special sub-sensory stimulation treatment, so you will not feel anything during this period as the stimulus is set at a very low, non-detectable threshold. Please remain still during this 45-second period, letting your leg rest passively in the machine without contracting your leg muscles. After the 45-second period, the stimulation unit will be turned off and you will have a 2-minute rest period. We will repeat this same treatment/rest sequence 5 total times."
5 sets of 45-seconds intervals without quadriceps contraction, each followed by 2-minutes of rest.
Other Names:
  • Sham TENS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in the change in mean internal knee extension moment during landing between groups
Time Frame: Pre- and post-intervention condition (~30 minutes)
Angular force or moment will be measured in Nm/kg*m where "Nm" represents angular force and "kg*m" represents normalization to body weight and height.
Pre- and post-intervention condition (~30 minutes)
Difference in the change in mean internal hip flexion moment during landing between groups
Time Frame: Pre- and post-intervention condition (~30 minutes)
Angular force or moment will be measured in Nm/kg*m where "Nm" represents angular force and "kg*m" represents normalization to body weight and height.
Pre- and post-intervention condition (~30 minutes)
Difference in the change in mean peak vertical ground reaction force during landing between groups
Time Frame: Pre- and post-intervention condition (~30 minutes)
Vertical ground reaction force will be measured in N(BW) where "N" is a measure of force and "BW" represents normalization to body weight.
Pre- and post-intervention condition (~30 minutes)
Difference in the change in mean peak vertical ground reaction force loading rate during landing between groups
Time Frame: Pre- and post-intervention condition (~30 minutes)
Vertical ground reaction force loading rate will be measured in N(BW)/s where "N" is a measure of force and "BW" represents normalization to body weight and "s" is the time unit seconds.
Pre- and post-intervention condition (~30 minutes)
Difference in the change in mean peak patellar tendon force during landing between groups
Time Frame: Pre- and post-intervention condition (~30 minutes)
Patellar tendon force will be measured in N(BW) where "N" is a measure of force and "BW" represents normalization to body weight.
Pre- and post-intervention condition (~30 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in average steps-per-day between groups
Time Frame: Day 1 - Day 7
Steps-per-day calculated by an ActiGraph GT9X Link Accelerometer (ActiGraph Corporation, Pensacola, FL) wearable physical activity device worn at the hip using a belt clip.
Day 1 - Day 7
Difference in average minutes of moderate-to-vigorous physical activity (MVPA) between groups
Time Frame: Day 1 - Day 7
MVPA calculated by an ActiGraph GT9X Link Accelerometer (ActiGraph Corporation, Pensacola, FL) wearable physical activity device worn at the hip using a belt clip.
Day 1 - Day 7
Difference in change in anterior knee pain (self-reported via visual analog scale (0-10)) between groups
Time Frame: Pre- and post-intervention condition (~10 minutes)
A standard visual analog scale (0-10) will be utilized to assess pain, where 0=complete absence of pain and 10=worst pain imaginable (higher scores indicate worse pain). This scale will be delivered verbally and the participants will respond verbally.
Pre- and post-intervention condition (~10 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Darin A Padua, PhD, ATC, Professor and Department Chair
  • Principal Investigator: Laura E Stanley, DPT, Graduate Research Assistant

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 15, 2017

Primary Completion (ACTUAL)

April 20, 2018

Study Completion (ACTUAL)

April 20, 2018

Study Registration Dates

First Submitted

August 22, 2017

First Submitted That Met QC Criteria

August 22, 2017

First Posted (ACTUAL)

August 25, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 19, 2019

Last Update Submitted That Met QC Criteria

February 15, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendinopathy

Clinical Trials on Isometric Exercise

Subscribe